Tag: tirzepatide
Popular obesity drugs deliver weight loss but fail to improve quality of life or heart health, meta-analysis reveals
A meta-analysis published in The BMJ found that popular obesity drugs such as semaglutide and tirzepatide produce substantial weight loss…
U.S. Healthcare Spending Surged 7.3% in 2025, Driven by GLP-1 Adoption and Increased Care Utilization
U.S. healthcare spending surged 7.3% to approximately $6 trillion in 2025, driven by widespread adoption of expensive GLP-1 weight-loss and…
Beyond GLP-1 drugs: Why obesity care requires more than medication
GLP-1 medications like semaglutide and tirzepatide have transformed obesity treatment, yet leading specialists warn that medication alone is insufficient. Sustainable…
Submit Your Paper to GMJ
No APC until January 2027.